Why is Jenburkt Pharma falling/rising?

As of 15-Sep, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 1,097.95, reflecting a decrease of 0.55 or 0.05%. The stock has underperformed in recent periods, with a 4.23% drop over the past week and a 6.10% decline over the past month. Additionally, it is trading below all key moving averages, indicating a bearish trend. Investor participation has also decreased significantly, with delivery volume falling by 71.86% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, Jenburkt Pharmaceuticals' recent performance contrasts sharply with the benchmark, as the Sensex has gained 1.24% over the past week and 1.47% over the past month. Year-to-date, the stock has declined by 9.61%, while the Sensex has increased by 4.67%. This underperformance highlights a challenging environment for Jenburkt Pharmaceuticals, as it struggles to attract investor interest amidst a generally positive market backdrop.